TTM
$6.30B
YoY change
+11.5%
5Y CAGR
+6.7%
Peak year (2025)
$6.07B
Cumulative revenue
$70.11B
Revenue history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: $6.07B
Revenue growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: +11.5%
Revenue history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | $6.07B | +11.5% | +$628.10M | ||
| 2024 | $5.44B | +8.6% | +$429.50M | ||
| 2023 | $5.01B | -6.9% | −$372.40M | ||
| 2022 | $5.38B | +2.9% | +$149.90M | ||
| 2021 | $5.23B | +19.3% | +$846.20M | ||
| 2020 | $4.39B | +0.9% | +$38.30M | ||
| 2019 | $4.35B | +16.8% | +$625.20M | ||
| 2018 | $3.72B | +8.4% | +$287.50M | ||
| 2017 | $3.44B | +15.9% | +$471.60M | ||
| 2016 | $2.96B | +18.8% | +$470.00M | ||
| 2015 | $2.49B | +7.4% | +$170.80M | ||
| 2014 | $2.32B | +13.6% | +$277.40M | ||
| 2013 | $2.05B | +7.7% | +$145.90M | ||
| 2012 | $1.90B | +13.2% | +$221.00M | ||
| 2011 | $1.68B | +16.0% | +$231.60M | ||
| 2010 | $1.45B | +9.5% | +$125.60M | ||
| 2009 | $1.32B | +6.8% | +$83.70M | ||
| 2008 | $1.24B | +13.4% | +$146.60M | ||
| 2007 | $1.09B | +5.2% | +$54.10M | ||
| 2006 | $1.04B | +3.9% | +$39.10M | ||
| 2005 | $997.90M | +7.1% | +$66.40M | ||
| 2004 | $931.50M | +8.3% | +$71.00M | ||
| 2003 | $860.50M | +22.2% | +$156.50M | ||
| 2002 | $704.00M | +1.7% | +$12.00M | ||
| 2001 | $692.00M | -13.9% | −$112.00M | ||
| 2000 | $804.00M | -11.2% | −$101.00M | ||
| 1999 | $905.00M | — | — |
- 2025$6.07B+11.5%
- 2024$5.44B+8.6%
- 2023$5.01B-6.9%
- 2022$5.38B+2.9%
- 2021$5.23B+19.3%
- 2020$4.39B+0.9%
- 2019$4.35B+16.8%
- 2018$3.72B+8.4%
- 2017$3.44B+15.9%
- 2016$2.96B+18.8%
- 2015$2.49B+7.4%
- 2014$2.32B+13.6%
- 2013$2.05B+7.7%
- 2012$1.90B+13.2%
- 2011$1.68B+16.0%
- 2010$1.45B+9.5%
- 2009$1.32B+6.8%
- 2008$1.24B+13.4%
- 2007$1.09B+5.2%
- 2006$1.04B+3.9%
- 2005$997.90M+7.1%
- 2004$931.50M+8.3%
- 2003$860.50M+22.2%
- 2002$704.00M+1.7%
- 2001$692.00M-13.9%
- 2000$804.00M-11.2%
- 1999$905.00M—
Revenue values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current revenue (TTM) is $6.30B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Edwards Lifesciences (EW) most recent annual revenue stands at $6.07B (2025) – grew 11.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Edwards Lifesciences revenue compounded at +6.7% per year, sustaining 2 straight years of year-over-year growth.
The highest annual revenue of $6.07B was reported in 2025. The lowest in the available history was $692.00M in 2001.
Edwards Lifesciences Revenue by Year
Edwards Lifesciences Revenue 2025: $6.07B
Edwards Lifesciences posted revenue of $6.07B in 2025, grew 11.5% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Revenue 2024: $5.44B
In 2024, Edwards Lifesciences reported revenue of $5.44B, grew 8.6% from 2023.
Edwards Lifesciences Revenue 2023: $5.01B
Edwards Lifesciences revenue in 2023 was $5.01B, declined 6.9% below 2022.
Edwards Lifesciences Revenue 2022: $5.38B
2022's revenue for Edwards Lifesciences came in at $5.38B, edged up 2.9% from 2021.
Edwards Lifesciences Revenue 2021: $5.23B
Edwards Lifesciences revenue in 2021 was $5.23B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Revenue
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation